//php print_r(get_the_ID()); ?>
Context:
The Medicines Patent Pool (MPP) has signed sub licence agreements with the India based companies Eugia, Hetero and Dr. Reddy’s Laboratories, along with the Indonesian firm BrightGene, to make generic versions of the drug Nilotinib.
What is Nilotinib?
About Medicines Patent Pool:
News Source: The Hindu
To get PDF version, Please click on "Print PDF" button.
How Clean Energy Needs, New Tech Shape Mineral Gov...
Stepping Stone: On Shubhanshu Shukla, NASA-Axiom-I...
How is Global Shipping trying to Decarbonise?
Contesting the Future of Forest Governance
A Tectonic Shift in Thinking to Build Seismic Resi...
Safe Havens No More: On Growing Crime Against Wome...
Monsoon Session of Parliament 2025: 21 Sittings, 8...
Language, Culture, and Identity in India
Indian Army Tests Akash Prime in Ladakh, Boosting ...
Banni Grasslands in Gujarat Ready to Host Cheetahs...
CWC Warns NGT: 34 Glacial Lakes in India Expanding...
Coronal Mass Ejections (CMEs) Trigger Rare Norther...
<div class="new-fform">
</div>